Enanta Pharmaceuticals Ownership | Who Owns Enanta Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Enanta Pharmaceuticals Ownership Summary

Enanta Pharmaceuticals is owned by 27.35% institutional investors, 6.19% insiders, and 66.46% retail investors. Farallon capital management is the largest institutional shareholder, holding 9.96% of ENTA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.95% of its assets in Enanta Pharmaceuticals shares.

ENTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Enanta Pharmaceuticals	27.35%	6.19%	66.46%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Farallon capital management	2.11M	9.96%	$12.12M
Blackrock funding, inc. /de	2.04M	9.64%	$11.73M
Vanguard group	1.98M	9.38%	$11.41M
Blackrock	1.85M	8.72%	$23.96M
Morgan stanley	1.46M	6.88%	$18.89M
Krensavage asset management	1.25M	5.91%	$16.23M
Ra capital management	1.04M	4.91%	$5.97M
Marshall wace, llp	930.09K	4.40%	$5.35M
Millennium management	896.99K	4.24%	$5.16M
Acadian asset management	849.42K	4.01%	$4.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Krensavage asset management	1.25M	7.45%	$16.23M
Stonepine capital management	331.90K	1.54%	$1.91M
Sio capital management	177.00K	0.29%	$1.02M
Caligan partners lp	184.83K	0.27%	$1.06M
Ra capital management	1.04M	0.08%	$5.97M
Oxford asset management llp	23.76K	0.07%	$136.63K
Velan capital investment management lp	13.00K	0.06%	$74.75K
Farallon capital management	2.11M	0.06%	$12.12M
Sherbrooke park advisers	33.45K	0.06%	$192.34K
Tang capital management	126.66K	0.05%	$728.27K

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	1.04M	0.08%	1.04M
Stonepine capital management	331.90K	1.54%	331.90K
Millennium management	896.99K	0.00%	165.69K
Blackrock funding, inc. /de	2.04M	0.00%	139.32K
Krensavage asset management	1.25M	7.45%	126.75K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.00M
Soleus capital management	-	-	-785.55K
Morgan stanley	1.46M	0.00%	-588.59K
Ameriprise financial	70.43K	0.00%	-257.88K
Caligan partners lp	184.83K	0.27%	-137.63K

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	1.04M	0.08%	1.04M	$5.97M
Stonepine capital management	331.90K	1.54%	331.90K	$1.91M
Thrivent financial for lutherans	44.10K	0.00%	44.10K	$254.00K
Norges bank	40.70K	-	40.70K	$234.03K
Sherbrooke park advisers	33.45K	0.06%	33.45K	$192.34K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-4.00
Innealta capital	-16.00
Voisard asset management group	-28.00
Gamma investing	-29.00
Quadrant capital group	-35.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	32	-71.17%	5,786,937	-72.69%	27	0.27%	17	-69.09%	9	-71.88%
Sep 30, 2024	111	11.00%	21,189,162	-3.74%	100	0.93%	56	27.27%	32	-27.27%
Jun 30, 2024	100	-6.54%	22,011,926	-1.25%	103	0.94%	44	4.76%	44	-12.00%
Mar 31, 2024	107	1.90%	22,290,570	11.98%	105	1.18%	42	-22.22%	50	16.28%
Dec 31, 2023	105	-19.85%	19,906,154	-1.08%	94	1.03%	54	-22.86%	43	-2.27%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	629.60K	2.95%	-
Vanguard Total Stock Mkt Idx Inv	629.60K	2.95%	-
iShares Russell 2000 ETF	534.54K	2.51%	-4.62K
Vanguard Strategic Small-Cap Equity Inv	300.76K	1.41%	-
Vanguard Institutional Extnd Mkt Idx Tr	294.95K	1.38%	13.34K
Columbia Small Cap Value I A	271.73K	1.28%	3.30K
Vanguard VIF Small Co Gr	253.37K	1.19%	-
Columbia Small Cap Value I	200.68K	0.95%	200.68K
Fidelity Small Cap Index	200.20K	0.94%	-3.75K
iShares Russell 2000 Value ETF	181.38K	0.85%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 12, 2025	Luly Jay R.	President and CEO	Buy	$256.05K
Dec 06, 2024	Kieffer Tara Lynn	Chief Product Strategy Officer	Sell	$18.40K
Dec 06, 2024	Luu Brendan	Chief Business Officer	Sell	$18.40K
Dec 06, 2024	Rottinghaus Scott T.	Chief Medical Officer	Sell	$6.98K
Dec 06, 2024	Or Yat Sun	Chief Scientific Officer	Sell	$20.88K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	1	-
2024 Q4	-	6
2024 Q3	-	3
2024 Q2	-	1
2024 Q1	-	-

ENTA Ownership FAQ

Who Owns Enanta Pharmaceuticals?

Enanta Pharmaceuticals shareholders are primarily institutional investors at 27.35%, followed by 6.19% insiders and 66.46% retail investors. The average institutional ownership in Enanta Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Enanta Pharmaceuticals falls below.

Who owns the most shares of Enanta Pharmaceuticals?

Enanta Pharmaceuticals’s largest shareholders are Farallon capital management (2.11M shares, 9.96%), Blackrock funding, inc. /de (2.04M shares, 9.64%), and Vanguard group (1.98M shares, 9.38%). Together, they hold 28.98% of Enanta Pharmaceuticals’s total shares outstanding.

Does Blackrock own Enanta Pharmaceuticals?

Yes, BlackRock owns 8.72% of Enanta Pharmaceuticals, totaling 1.85M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 23.96M$. In the last quarter, BlackRock increased its holdings by 8.46K shares, a 0.46% change.

Who is Enanta Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Enanta Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.45% of its assets in 1.25M Enanta Pharmaceuticals shares, valued at 16.23M$.

Who is the top mutual fund holder of Enanta Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Enanta Pharmaceuticals shares, with 2.95% of its total shares outstanding invested in 629.6K Enanta Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools